Enzyme Replacement and Immunosuppression in Heart Transplant Recipients with Fabry Cardiomyopathy: A 7-Year Case Study

Katarzyna Muras-Szwedziak; Maciej Wójcik; Olga Wojtyczka; Krzysztof Kaczmarek

doi:10.12659/AJCR.945873

17 March 2025 : Case report Poland

Enzyme Replacement and Immunosuppression in Heart Transplant Recipients with Fabry Cardiomyopathy: A 7-Year Case Study

Challenging differential diagnosis, Unusual or unexpected effect of treatment, Rare disease

Katarzyna Muras-Szwedziak

^{ABCDEF 1}, Maciej Wójcik

^{ABCDEF 2}, Olga Wojtyczka

^{ABCDEF 2*}, Krzysztof Kaczmarek

^{ABCDEF 3}

DOI: 10.12659/AJCR.945873

Am J Case Rep 2025; 26:e945873

Authors information Article notes Copyright and License information

Introduction Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 2. Changes in the values of biochemical markers (NT-proBNP, hsTnT, CK-MB mass, lyso-GL-3) during follow-up. The heart transplant was performed on June 2nd, 2016.

Back to the Article

Enzyme Replacement and Immunosuppression in Heart Transplant Recipients with Fabry Cardiomyopathy: A 7-Year Case Study

Your Privacy